Profiles

Keywords
Last Name
Institution

Connection

Amir Jaffer to Anticoagulants

This is a "connection" page, showing publications Amir Jaffer has written about Anticoagulants.

 
Connection Strength
 
 
 
6.686
 
  1. Kim J, Huh R, Jaffer AK. Perioperative Approach to Anticoagulants and Hematologic Disorders. Anesthesiol Clin. 2016 Mar; 34(1):101-25.
    View in: PubMed
    Score: 0.525
  2. Eymin G, Jaffer AK. Evidence behind quality of care measures for venous thromboembolism and atrial fibrillation. J Thromb Thrombolysis. 2014; 37(2):87-96.
    View in: PubMed
    Score: 0.452
  3. Eymin G, Jaffer AK. Evidence behind quality of care measures for venous thromboembolism and atrial fibrillation. J Thromb Thrombolysis. 2014; 37(2):87-96.
    View in: PubMed
    Score: 0.452
  4. Eymin G, Jaffer AK. Thromboprophylaxis in major knee and hip replacement surgery: a review. J Thromb Thrombolysis. 2012 Nov; 34(4):518-25.
    View in: PubMed
    Score: 0.417
  5. Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med. 2010 Feb; 123(2):141-50.
    View in: PubMed
    Score: 0.344
  6. Jaffer AK. Perioperative management of warfarin and antiplatelet therapy. Cleve Clin J Med. 2009 Nov; 76 Suppl 4:S37-44.
    View in: PubMed
    Score: 0.338
  7. Grant PJ, Brotman DJ, Jaffer AK. Perioperative anticoagulant management. Med Clin North Am. 2009 Sep; 93(5):1105-21.
    View in: PubMed
    Score: 0.334
  8. Jaffer AK. Venous thromboembolism (VTE). Cleve Clin J Med. 2008 Apr; 75 Suppl 3:S2.
    View in: PubMed
    Score: 0.303
  9. Jaffer AK. Managing anticoagulant related coagulopathy. J Thromb Thrombolysis. 2008 Feb; 25(1):85-90.
    View in: PubMed
    Score: 0.294
  10. Grant PJ, Jaffer AK. When should prophylactic anticoagulation begin after a hip fracture? Cleve Clin J Med. 2006 Sep; 73(9):785-6, 788, 790-2.
    View in: PubMed
    Score: 0.272
  11. Jaffer AK. Anticoagulation management strategies for patients on warfarin who need surgery. Cleve Clin J Med. 2006 Mar; 73 Suppl 1:S100-5.
    View in: PubMed
    Score: 0.262
  12. Jaffer AK, Brotman DJ. Prevention of venous thromboembolism in the geriatric patient. Clin Geriatr Med. 2006 Feb; 22(1):93-111, ix.
    View in: PubMed
    Score: 0.261
  13. Jaffer AK, Ahmed M, Brotman DJ, Bragg L, Seshadri N, Qadeer MA, Klein A. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. J Thromb Thrombolysis. 2005 Aug; 20(1):11-6.
    View in: PubMed
    Score: 0.252
  14. Jaffer AK, Brotman DJ, Michota F. Current and emerging options in the management of venous thromboembolism. Cleve Clin J Med. 2005 Apr; 72 Suppl 1:S14-23.
    View in: PubMed
    Score: 0.246
  15. Jaffer AK, Brotman DJ, Chukwumerije N. When patients on warfarin need surgery. Cleve Clin J Med. 2003 Nov; 70(11):973-84.
    View in: PubMed
    Score: 0.223
  16. Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial. JAMA. 2019 09 03; 322(9):834-842.
    View in: PubMed
    Score: 0.167
  17. Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodríguez T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA. 2017 09 26; 318(12):1115-1124.
    View in: PubMed
    Score: 0.146
  18. Moseley A, Doukky R, Williams KA, Jaffer AK, Volgman AS. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation. J Womens Health (Larchmt). 2017 03; 26(3):214-221.
    View in: PubMed
    Score: 0.138
  19. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27; 373(9):823-33.
    View in: PubMed
    Score: 0.125
  20. Kovacs RJ, Flaker GC, Saxonhouse SJ, Doherty JU, Birtcher KK, Cuker A, Davidson BL, Giugliano RP, Granger CB, Jaffer AK, Mehta BH, Nutescu E, Williams KA. Practical management of anticoagulation in patients with atrial fibrillation. J Am Coll Cardiol. 2015 Apr 07; 65(13):1340-1360.
    View in: PubMed
    Score: 0.123
  21. Colantino A, Jaffer AK, Brotman DJ. Resuming anticoagulation after hemorrhage: A practical approach. Cleve Clin J Med. 2015 Apr; 82(4):245-56.
    View in: PubMed
    Score: 0.123
  22. Dutta S, Jaffer AK, Slawski BA, Pfeifer KJ, Smetana GW, Cohn SL. Perioperative anticoagulation and renal disease: an update. Hosp Pract (1995). 2014 Dec; 42(5):132-8.
    View in: PubMed
    Score: 0.120
  23. Jove M, Maslanka M, Minkowitz HS, Jaffer AK. Safety of desirudin in thrombosis prevention after total knee arthroplasty: the DESIR-ABLE study. Am J Ther. 2014 Nov-Dec; 21(6):496-9.
    View in: PubMed
    Score: 0.120
  24. Cohn SL, Mauck KF, Dutta S, Jaffer A, Smetana GW. Update in perioperative medicine 2013. Hosp Pract (1995). 2013 Oct-Nov; 41(4):15-23.
    View in: PubMed
    Score: 0.111
  25. Shorr AF, Eriksson BI, Jaffer AK, Smith J. Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial. J Thromb Haemost. 2012 Aug; 10(8):1515-20.
    View in: PubMed
    Score: 0.102
  26. Lenchus JD, Jaffer AK. Prevention of venous thromboembolism in hospitalized medical patients. Mt Sinai J Med. 2008 Oct; 75(5):449-53.
    View in: PubMed
    Score: 0.078
  27. Garcia DA, Witt DM, Hylek E, Wittkowsky AK, Nutescu EA, Jacobson A, Moll S, Merli GJ, Crowther M, Earl L, Becker RC, Oertel L, Jaffer A, Ansell JE. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother. 2008 Jul; 42(7):979-88.
    View in: PubMed
    Score: 0.077
  28. Brotman DJ, Jaffer AK. Prevention of venous thromboembolism in the geriatric patient. Cardiol Clin. 2008 May; 26(2):221-34, vi.
    View in: PubMed
    Score: 0.076
  29. Jaffer AK. An overview of venous thromboembolism: impact, risks, and issues in prophylaxis. Cleve Clin J Med. 2008 Apr; 75 Suppl 3:S3-6.
    View in: PubMed
    Score: 0.076
  30. Jaffer AK, Amin AN, Brotman DJ, Deitelzweig SB, McKean SC, Spyropoulos AC. Prevention of venous thromboembolism in the hospitalized medical patient. Cleve Clin J Med. 2008 Apr; 75 Suppl 3:S7-16.
    View in: PubMed
    Score: 0.076
  31. Colantino A, Jaffer AK, Brotman DJ. In Reply: Resuming anticoagulation after hemorrhage. Cleve Clin J Med. 2015 10; 82(10):640.
    View in: PubMed
    Score: 0.032
  32. Deitelzweig SB, McKean SC, Amin AN, Brotman DJ, Jaffer AK, Spyropoulos AC. Prevention of venous thromboembolism in the orthopedic surgery patient. Cleve Clin J Med. 2008 Apr; 75 Suppl 3:S27-36.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.